CPTAC Establishes Formal Relationships with Two Academic Institutions in Taiwan
News Aug 18, 2015
These organizations agree to develop international cooperation on using proteomic methods to characterize tumors and compare findings to other diagnostic features including genomic characterization. The motivation for these MOUs is to gain a deeper understanding of cancer at the molecular level, identify targets and pathways of therapeutic intervention, share knowledge and experience in support each other's endeavors in proteogenomics science, and promote the development and adoption of standards in basic and clinical medicine.
“Tracking” Nanoagents Can Illuminate Very Small Diseased TissuesNews
Polymer nanoagents that can ‘light up’ tiny areas of diseased tissues that conventional methods fail to detect, have been created by a research team led by Nanyang Technological University, Singapore.READ MORE
Training Evolution in Pathology Needed to Deliver Precision MedicineNews
The future delivery of precision medicine is at risk unless pathology training programmes evolve to embrace genomics, warn UK researchers.READ MORE